Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid S Boland

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Inflammatory Bowel Diseases|October 9, 2018
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative ColitisRobert Battat, Parambir S Dulai, Niels Vande Casteele, et al.
Clinical and Translational Gastroenterology|January 19, 2018
Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel diseaseAhmed Moustafa, Weizhong Li, Ericka L Anderson, et al.
The American Journal of Gastroenterology|May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule InhibitorsParambir S Dulai, Robert Battat, Maria Barsky, et al.
Inflammatory Bowel Diseases|December 30, 2014
Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseBrigid S Boland, David L Boyle, William J Sandborn, et al.
Crohn'S & Colitis 360|December 16, 2024
Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab TherapyRochelle Wong, Paris Charilaou, Amy Hemperly, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Stromal state plasticity defines risk and therapeutic opportunity in recalcitrant inflammatory bowel diseaseCourtney Tindle, Harrison M Penrose, Saptarshi Sinha, et al.
Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Precision MedicineSana Syed, Brigid S Boland, Lauren T Bourke, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating TherapiesBrigid S Boland, Benjamin Goodwin, Zeli Zhang, et al.
Clinical and Translational Gastroenterology|February 28, 2023
Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's DiseaseHan G Duong, Eunice J Choi, Paul Hsu, et al.
Gut|June 22, 2016
The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1Samuel Bertin, Yukari Aoki-Nonaka, Jihyung Lee, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Inflammatory Bowel Diseases|October 9, 2018
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative ColitisRobert Battat, Parambir S Dulai, Niels Vande Casteele, et al.
Clinical and Translational Gastroenterology|January 19, 2018
Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel diseaseAhmed Moustafa, Weizhong Li, Ericka L Anderson, et al.
The American Journal of Gastroenterology|May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule InhibitorsParambir S Dulai, Robert Battat, Maria Barsky, et al.
Inflammatory Bowel Diseases|December 30, 2014
Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseBrigid S Boland, David L Boyle, William J Sandborn, et al.
Crohn'S & Colitis 360|December 16, 2024
Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab TherapyRochelle Wong, Paris Charilaou, Amy Hemperly, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Stromal state plasticity defines risk and therapeutic opportunity in recalcitrant inflammatory bowel diseaseCourtney Tindle, Harrison M Penrose, Saptarshi Sinha, et al.
Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Precision MedicineSana Syed, Brigid S Boland, Lauren T Bourke, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating TherapiesBrigid S Boland, Benjamin Goodwin, Zeli Zhang, et al.
Clinical and Translational Gastroenterology|February 28, 2023
Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's DiseaseHan G Duong, Eunice J Choi, Paul Hsu, et al.
Gut|June 22, 2016
The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1Samuel Bertin, Yukari Aoki-Nonaka, Jihyung Lee, et al.
Pageof 10